Closed spinal dysraphism is a congenital condition where the spine and spinal cord do not fully form. Many people with closed spinal dysraphism have no symptoms, but some develop leg weakness, foot deformities, back pain, or bladder and bowel problems. Signs often appear in infancy or childhood, and the condition is lifelong. Imaging helps confirm the diagnosis, and treatment may include monitoring, physical therapy, and surgery if the cord is tethered or compressed. Most people with closed spinal dysraphism have a normal life span, but early care can prevent long‑term nerve damage.
Overview
Closed spinal dysraphismSymptoms
Closed spinal dysraphism may show a deep dimple, hairy patch, small lump, or birthmark over the spine. Some develop leg weakness, foot deformities, back pain, walking changes, or bladder/bowel problems. Signs can be noticed at birth or during childhood.
Outlook and prognosis
Most people with closed spinal dysraphism lead full lives, especially when it’s found early and care is tailored. Outlook varies: some have few symptoms, while others manage back pain, leg weakness, or bladder and bowel issues over time. Regular follow-up and timely treatment help protect function.
Causes and risk factors
Closed spinal dysraphism results from early neural tube formation not closing properly, shaped by genetic susceptibility. Risk rises with low folate, certain anti‑seizure medicines, maternal diabetes or obesity, fever/sauna heat, and family history. Adequate folic acid lowers risk.
Genetic influences
Genetics plays a role in Closed spinal dysraphism, but it’s typically multifactorial—genes interact with factors like folate status, diabetes, and certain medications. Most cases are sporadic. Family history slightly raises risk; recurrence risk is generally low but not zero.
Diagnosis
Diagnosis of closed spinal dysraphism starts with clinical features on the back (dimple, hair tuft, lump). Doctors confirm with imaging—spinal ultrasound in newborns and MRI later. Genetic tests may be considered if other anomalies suggest a syndrome.
Treatment and drugs
Treatment for closed spinal dysraphism is tailored to symptoms and MRI findings. Many do well with monitoring, physical therapy, and bladder/bowel support; neurosurgeons may untether the spinal cord or remove a fatty band to prevent nerve damage. Pain control and orthotics can help daily function.
Symptoms
Closed spinal dysraphism can show up in different ways, from small skin changes over the lower back to issues with walking, bladder control, or back pain as children grow. You might notice small changes at first, like a small dimple, patch of hair, or a soft lump along the spine. Early features of closed spinal dysraphism are often subtle, and some people don’t develop problems until later childhood or adulthood. Signs can vary widely depending on the exact type and where the spine is affected.
A small dimple, dark birthmark, patch of hair, or skin tag may sit over the lower spine. In closed spinal dysraphism, these marks are often centered on the midline and may be the only early clue.
A soft, fatty bump under the skin can form over the lower back. In closed spinal dysraphism, this lump may connect to deeper tissues.
A pinhole or pit in the skin can lead downward and sometimes leaks clear fluid. This can increase infection risk and should be checked promptly.
One or both legs may feel weak, heavy, or less coordinated. Tripping, frequent falls, or patchy numbness can appear over time.
How people usually first notice Closed spinal dysraphism?
Many families first notice closed spinal dysraphism when a newborn has a small skin change over the lower back—such as a dimple, tuft of hair, birthmark, fatty lump, or a tiny pit that sometimes leaks clear fluid. As babies grow, some develop subtle signs like asymmetric leg movement, foot deformities, or bladder and bowel problems, which prompt a pediatrician to order imaging to check the spine. These first signs of closed spinal dysraphism are often picked up during newborn exams or early well-child visits, and an ultrasound or MRI confirms how the spine formed.
Types of Closed spinal dysraphism
Closed spinal dysraphism includes a group of spinal cord and spine formation differences present from birth, but not open to the skin. People may have subtle skin changes over the lower back, leg weakness or numbness, bladder or bowel issues, or foot and spine shape changes that appear as a child grows. Clinicians often describe them in these categories: variants based on the tissue involved (fatty, bony, fibrous, or skin-related) and whether the spinal cord is tethered. Knowing the main variants can help you understand the different types of symptoms and how they may change over time.
Tethered cord
The spinal cord is abnormally anchored, limiting its movement. Symptoms often include back or leg pain, weakness, numbness, or changes in walking. Bladder or bowel control problems may develop or worsen during growth spurts.
Lipomyelomeningocele
A fatty mass connects to or involves the spinal cord beneath the skin. Many notice a soft lump over the lower back along with leg weakness or foot deformity. Bladder issues are common and may progress as a child grows.
Fatty filum terminale
The cord’s tail end is thickened with fatty tissue, sometimes tethering the cord. Symptoms can be subtle, such as intermittent leg pain, tight hamstrings, or toe-walking. Urinary urgency or accidents may appear in school-age years.
Diastematomyelia
The spinal cord is split into two parts by a bony or fibrous bar. Children may have a scoliosis check that first flags this, followed by findings like leg length differences or gait changes. Pain or numbness can appear later, especially with growth.
Dermal sinus tract
A small skin opening or dimple leads inward toward the spinal canal. Repeated drainage, a tuft of hair, or a tiny pit above the crease can be a clue. Infections and tethering symptoms like fever with back pain or new weakness need urgent attention.
Meningocele
The membranes around the cord pouch outward under the skin without cord tissue inside. Many are found on imaging after a skin finding, with few or no early symptoms. Larger sacs may cause local pain or pressure and can coexist with tethering.
Thickened filum
The filum terminale is abnormally thick and can tether the cord even without fat. Children may develop clumsiness, tripping, or new foot arch changes over time. Bladder control problems can be an early sign in some.
Cutaneous stigmata
Skin markers like a deep dimple, hemangioma, hair tuft, or asymmetrical gluteal crease sit over the lower spine. These surface signs can point to types of closed spinal dysraphism underneath. If present with leg or bladder symptoms, early imaging is often recommended to look for types of Closed spinal dysraphism.
What genetics can tell you about symptoms
Certain genetic variants affecting neural tube formation can raise the chance of tethered cord, foot deformities, or bladder and bowel problems in closed spinal dysraphism. Variants in folate-pathway or planar cell polarity genes may disrupt spine closure, linking to these symptoms.
Causes and risk factors
Closed spinal dysraphism starts before birth when the spinal tube does not close fully, and risk is shaped by inherited or new genetic susceptibility.
Pregnancy factors also play a role.
Common risk factors for closed spinal dysraphism include low folate around conception, certain anti-seizure medicines, poorly controlled diabetes, obesity, and high heat exposure from fever, hot tubs, or saunas in early pregnancy.
Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
Taking folic acid before and during early pregnancy lowers risk, and family history may raise it.
Environmental and biological risk factors
Closed spinal dysraphism develops very early in pregnancy, often before most people know they’re expecting. Understanding what can raise risk helps with planning, especially for those managing health conditions or medicines. Doctors often group risks into internal (biological) and external (environmental). Below are key environmental and biological risk factors for closed spinal dysraphism.
High blood sugar around conception can disrupt how the lower spine forms. When diabetes is present before pregnancy or not well managed in the first weeks, the risk of closed spinal dysraphism can be higher.
Fever or overheating in the first month of pregnancy can interfere with the spine’s early closure. Limiting prolonged heat exposure, like very hot tubs or saunas, during early pregnancy can help lower risk.
Some anti-seizure medications taken in early pregnancy are linked to a higher chance of spinal closure problems. If you need treatment, a specialist may adjust the plan before conception to help reduce the risk of closed spinal dysraphism.
Medicines that interfere with folate pathways, including some chemotherapy or autoimmune treatments, can raise risk during early development. Your care team may switch to alternatives when pregnancy is planned.
Genetic risk factors
Closed spinal dysraphism has a developmental genetic basis, and changes in genes that guide early spinal formation can raise risk. Experts have identified genetic risk factors for closed spinal dysraphism, but they can differ between families, reflecting a multifactorial pattern rather than a single cause. Carrying a genetic change doesn’t guarantee the condition will appear, but it can increase the chance a baby is affected. In a minority, a single-gene change or a small missing/extra piece of chromosome is identified.
Polygenic susceptibility: Many common genetic variants across several developmental pathways each add a small amount of risk. Together they can meaningfully increase the likelihood of the condition in a pregnancy. Family patterns often look complex rather than single-gene.
Family recurrence: Having one pregnancy or child with a neural tube defect slightly raises the chance in future pregnancies. For closed spinal dysraphism, this appears higher than baseline but still modest. A genetics professional can provide numbers tailored to your family.
Planar cell polarity: Rare changes in planar cell polarity genes (such as VANGL1, VANGL2, CELSR1, or PRICKLE) have been found in some people with the condition. These variants often show incomplete penetrance, meaning not everyone who carries one is affected. They may also contribute to related neural tube differences within a family.
Folate pathway variants: Inherited changes in folate-processing genes (for example MTHFR, MTRR, MTHFD1) can slightly increase susceptibility to neural tube defects. Evidence suggests they may play a role in some cases, but the effect of any single variant is usually small. These genetic influences act alongside many others.
Copy-number variants: Small deletions or duplications of DNA that include genes important for early spine development can raise risk. These can be found by chromosomal microarray testing in a subset of people with closed spinal dysraphism. They may be inherited or occur de novo.
Syndromic forms: A few genetic syndromes can include closed spinal dysraphism, such as Currarino syndrome linked to MNX1 changes. In these families, other features like sacral bone differences or a presacral mass point to a specific diagnosis. Identifying a syndrome helps refine recurrence risk and testing options.
Somatic mosaic variants: Some spinal lipomas and tethered cord lesions reflect changes that arise after conception in growth pathways (including PIK3CA-related overgrowth). These are usually mosaic and not inherited from a parent. Localized overgrowth can contribute to closed spinal dysraphism.
De novo variants: Occasionally, a new gene change is present in the child but not in either parent. When truly de novo, the chance of it happening again in a future pregnancy is typically low. Confirming whether a variant is de novo requires parental testing.
Lifestyle risk factors
Closed spinal dysraphism is present from birth; lifestyle habits do not cause it, but they can influence symptoms, day‑to‑day function, and complications over time. Understanding how lifestyle affects closed spinal dysraphism can help with pain, mobility, bowel/bladder control, and skin protection. The points below focus on practical ways habits may modify outcomes rather than on lifestyle risk factors for closed spinal dysraphism in a causative sense.
Gentle, regular movement (like walking, swimming, or adaptive exercise) can maintain mobility and reduce constipation. High‑impact or contact sports may aggravate back pain or neurological symptoms in tethered cord and related forms.
Excess body weight increases strain on the lower back and joints, potentially worsening pain and gait issues. Gradual weight control can ease mechanical stress and facilitate mobility aids or bracing.
Adequate fiber, fluids, and a consistent toileting routine help prevent constipation that can intensify abdominal pressure and discomfort. Bowel programs (with diet and timed emptying) may reduce soiling and improve quality of life.
Timed voiding, adequate hydration, and limiting bladder irritants (caffeine, alcohol, artificial sweeteners) may reduce urgency and leakage. Good bladder habits can also help lower urinary tract infection risk in neurogenic bladder.
Risk prevention
Closed spinal dysraphism often develops very early in pregnancy, so prevention focuses on steps taken before conception and in the first trimester. Folic acid lowers risk, but not all cases can be prevented. Pre-pregnancy health checks, medication review, and avoiding overheating during early pregnancy can also help. Some prevention is universal, others are tailored to people with specific risks.
Take 400 micrograms (0.4 mg) of folic acid every day starting at least 1 month before pregnancy and through the first trimester. This lowers the chance of neural tube problems like closed spinal dysraphism. Choose a prenatal vitamin or a folic acid–fortified supplement.
If you’ve had a prior neural tube defect pregnancy, take certain anti-seizure medicines, or have diabetes or obesity, ask about 4 mg daily. High-dose folic acid usually starts 1–3 months before conception and continues through 12 weeks. Your clinician will set the exact dose and timing.
Optimize blood sugar, blood pressure, thyroid health, and weight before trying to conceive. Quitting smoking and limiting alcohol support healthy fetal development. Talk to your doctor about which preventive steps are right for you.
Some drugs (for example, valproate) raise neural tube defect risk. Before pregnancy, discuss safer alternatives and the right folate dose if you need these medicines. Never stop a prescription without medical guidance.
Transmission
Closed spinal dysraphism is present at birth and is not contagious—you can’t catch it or pass it through contact. It arises early in pregnancy while the spine is forming and, for most families, occurs sporadically; how Closed spinal dysraphism is inherited is usually complex and not a simple one-gene pattern.
The chance is somewhat higher if a parent or a brother or sister has had a neural tube defect (including Closed spinal dysraphism), but for many families the background risk remains low. Rarely, genetic transmission of Closed spinal dysraphism occurs as part of a broader genetic condition; a genetics professional can review your family history and discuss personal recurrence risk.
When to test your genes
Consider genetic testing if closed spinal dysraphism appears with other birth differences, a strong family history of neural tube defects, or uncertain diagnosis on imaging. Testing helps clarify syndromic causes, guide surveillance for associated issues, and inform recurrence risk in future pregnancies. A genetics referral is also reasonable before planning another pregnancy.
Diagnosis
For many, the first hint is a small patch of hair, a dimple, or a fatty lump over the lower back, sometimes paired with foot differences or bladder trouble in childhood. Closed spinal dysraphism is usually identified by these outward clues and then confirmed with imaging. Doctors usually begin with a careful exam and then order tests that look closely at the spine and nerves. The goal is to confirm what’s present, understand how the nerves are affected, and guide treatment and follow-up.
Clinicians look for surface signs like a dimple, hemangioma, patch of hair, skin tag, or a soft lump along the spine. The location and grouping of these marks help point toward closed spinal dysraphism. Photos and measurements may be taken to track changes over time.
Providers test leg strength, reflexes, sensation, and walking pattern. Subtle weakness, toe-walking, or foot deformities can suggest tethered or stretched nerves. Findings guide which imaging tests are most urgent.
Doctors assess spine alignment, leg length, hip range, and foot shape. Scoliosis or clubfoot can be clues to closed spinal dysraphism. Early recognition can help protect growth and mobility.
In newborns and young infants, an ultrasound can visualize the lower spinal canal through the still-soft bones. It can show a low-lying cord, fatty masses, or a sinus tract. Abnormal results usually lead to MRI for full detail.
Stages of Closed spinal dysraphism
Closed spinal dysraphism does not have defined progression stages. It’s a group of birth differences in the spine and spinal cord that can be stable for years or change as a child grows, so it doesn’t follow a predictable step-by-step decline. Doctors usually start with a conversation about symptoms and development, then use exams and imaging such as ultrasound (in infants) or MRI to confirm the type and check for tethering or nerve pressure. Monitoring focuses on changes—like new leg weakness, bladder issues, foot shape, or back pain—because early symptoms of closed spinal dysraphism can be subtle, and follow-up helps decide if treatment or surgery is needed.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, and the answer depends on the specific type and whether nerves are affected. Closed spinal dysraphism ranges from mild forms that cause little to no day-to-day limits to situations where leg strength, bladder, or bowel control need ongoing care. The outlook is not the same for everyone, but early symptoms of closed spinal dysraphism like foot differences, back dimples with hair, or changes in toilet habits can flag issues that respond better when addressed sooner.
Prognosis refers to how a condition tends to change or stabilize over time. Many living with closed spinal dysraphism do well long term, especially when the spinal cord is not tethered or compressed; children and adults in this group often have normal life expectancy. When a tethered cord is present, surgery to release it can protect nerve function or slow decline, though it may not fully reverse symptoms that have been present for a long time. Some people experience periods of stability, while others notice gradual changes during growth spurts, pregnancy, or with weight gain that increases strain on the lower spine.
Even though it can feel overwhelming, most people with closed spinal dysraphism can attend school, work, and stay active with the right mix of follow-up, physical therapy, and bladder or bowel programs. Serious complications are uncommon when care is consistent; mortality directly due to closed spinal dysraphism is rare in modern care, and overall life span is typically near normal. Knowing what to expect can ease some of the worry. Talk with your doctor about what your personal outlook might look like, including triggers for symptom changes and when to consider imaging or surgical review.
Long-term effects
Closed spinal dysraphism can have lasting effects that touch movement, bladder and bowel control, and day-to-day comfort. People sometimes hear about early symptoms of closed spinal dysraphism, but for many the long-term picture becomes clearer across school years, adolescence, and adulthood. Long-term effects vary widely, and two people with similar scans can have very different experiences. Some features stay steady for years, while others can slowly change, especially during growth spurts or later in life.
Subtle leg weakness can make running, stairs, or uneven ground harder. Over time, this can lead to tripping, slower walking, or trouble keeping up.
Ongoing low-back or shooting leg pain can flare with activity or long sitting. For some, pain increases during growth or after long workdays.
Numbness, tingling, or reduced temperature and pain sensing can affect the feet or legs. These changes can be patchy and may slowly spread or intensify.
Urgency, leakage, or difficulty emptying the bladder can persist long-term. Repeated urinary infections and, in some cases, kidney strain can develop if emptying remains incomplete.
How is it to live with Closed spinal dysraphism?
Living with closed spinal dysraphism can range from barely noticeable day to day to a steady routine of managing back discomfort, leg weakness, or bladder and bowel control issues. Many find that planning—regular bathroom schedules, skin checks, tailored exercise, and occasional physical therapy—helps preserve independence and reduce flare-ups, while periodic check-ins with neurosurgery or urology track changes that might need treatment. School, work, and family life can adapt with small accommodations like extra time for rest, accessible seating, or discreet continence supplies, which often ease stress for both the person and those around them. With clear communication and a practical plan, most people build a reliable rhythm that supports mobility, dignity, and participation in the activities that matter.
Treatment and drugs
Treatment for closed spinal dysraphism focuses on protecting nerve function, easing symptoms, and preventing future problems. Care is often led by a neurosurgeon with input from rehabilitation, urology, and physical therapy; some people need only monitoring with periodic exams and imaging, while others benefit from surgery to release a tethered spinal cord, remove a fatty mass (lipoma), or address a fluid-filled cavity (syrinx) if there are signs of nerve pressure or worsening function. Supportive care can make a real difference in how you feel day to day, including pelvic floor therapy and bladder training, bowel programs, skin protection, and tailored exercises to maintain strength and balance. Medicines that ease symptoms are called symptomatic treatments and may include pain relievers for nerve pain, bladder relaxants for urgency or leakage, stool softeners or laxatives for constipation, and antibiotics if urinary infections occur. Your doctor can help weigh the pros and cons of each option, and surgery is typically considered when early symptoms of closed spinal dysraphism—such as new leg weakness, back or leg pain, or changes in bladder or bowel control—appear or progress.
Non-drug treatment
For closed spinal dysraphism, non-drug care aims to protect nerve function, ease bladder and bowel issues, and support movement and comfort. Non-drug treatments often lay the foundation for daily function and safety, whether or not surgery is part of care. Plans are tailored by age, symptoms, and exam findings. Teams often include rehabilitation, urology, continence care, and neurosurgery specialists.
Routine checks for leg strength, sensation, foot shape, and back skin changes help catch new issues early. Watch for early symptoms of closed spinal dysraphism such as new bladder leakage, trouble starting urine flow, or worsening leg weakness. Report sudden changes to your care team promptly.
Targeted exercises build strength, flexibility, and balance to improve walking and reduce falls. In closed spinal dysraphism, gentle core and hip work can reduce strain on the lower spine. Therapists also coach posture and safe movement for daily tasks.
Bladder training, pelvic floor exercises, and biofeedback can improve control and reduce accidents. Structured programs, like timed voiding with pelvic floor training, can help reset bathroom routines.
A regular schedule, fiber-rich meals, and adequate fluids support predictable bowel movements. Positioning, abdominal massage, and pelvic floor coordination can ease constipation and reduce leakage. Care plans adapt as children grow or adult routines change.
Your genes may have an impact on how drugs work for you
Medications used around closed spinal dysraphism—like pain relievers, muscle relaxants, or anesthetics—can work differently because gene variants affect how bodies absorb, activate, and clear drugs. Pharmacogenetic testing can sometimes guide dosing, reduce side effects, and improve comfort and safety.
Pharmacological treatments
Medicines for closed spinal dysraphism focus on easing day-to-day problems like pain, bladder or bowel issues, and muscle tightness. Surgery addresses the underlying tether or malformation when needed, but medicines can make daily routines safer and more comfortable. You might picture medicine as one tool among many—alongside physical therapy, bladder and bowel retraining, and, when needed, surgery. The options below are commonly used, tailored to symptoms and age.
Over-the-counter pain relievers like acetaminophen (paracetamol) and NSAIDs such as ibuprofen or naproxen can ease back or leg pain. They help many with closed spinal dysraphism during flare-ups or after activity. Use the lowest effective dose, and avoid NSAIDs if your doctor has advised against them.
Gabapentin, pregabalin, duloxetine, or low-dose amitriptyline can calm nerve-driven pain, tingling, or burning. Not everyone responds to the same medication in the same way. Your doctor may adjust the dose slowly to balance relief and side effects like sleepiness or dry mouth.
Lidocaine patches or gels and capsaicin cream can numb or quiet small, painful areas. For some, early symptoms of closed spinal dysraphism like localized back pain are more manageable with these skin-applied treatments. They can be combined with oral medicines if needed.
Baclofen or tizanidine relax tight muscles and reduce spasms; diazepam may be used short term. Dosing may be increased or lowered gradually to improve comfort without excessive drowsiness. For focal tightness, botulinum toxin injections can target a specific muscle.
Genetic influences
In most people, closed spinal dysraphism happens because of a mix of inherited susceptibility and factors in early pregnancy, rather than a single cause. Family history is one of the strongest clues to a genetic influence. Still, most cases are sporadic, and even when one child is affected, the chance of it happening again in a future pregnancy is only modestly higher than average. Researchers have linked neural tube defects to many genes that guide early spine development—often acting more like dimmer switches than on/off switches—and to how those genes interact with folate levels, certain medicines, diabetes, obesity, or fever in early pregnancy. Rare families have a single-gene syndrome, such as Currarino syndrome, where the spinal defect appears along with other features, and in those situations genetic testing may be helpful. Genetic results, when available, estimate risk; they don’t predict the course or early symptoms of closed spinal dysraphism, and decisions about testing are best made with a specialist who knows your family’s history.
Is Closed spinal dysraphism genetic?
Genetics plays a role in Closed spinal dysraphism, but it’s typically multifactorial—genes interact with factors like folate status, diabetes, and certain medications. Most cases are sporadic. Family history slightly raises risk; recurrence risk is generally low but not zero.
Pharmacogenetics—how genetics influence drug effects
Genetics don’t usually change whether someone with Closed spinal dysraphism needs surgery, but they can shape how well certain medicines work and which ones are safest. These genetic factors affecting medication response in Closed spinal dysraphism most often come up with pain control, bladder medicines, and anesthesia for spine surgery. Differences in drug‑processing genes can change how people respond to opioids like codeine or tramadol and to some anti‑inflammatory drugs such as ibuprofen or diclofenac, so your team may choose a different drug or adjust the dose if your body breaks these medicines down unusually slowly or quickly. If nerve pain is treated with certain antidepressants used for pain, such as amitriptyline or nortriptyline, enzyme differences may point to a lower starting dose to reduce side effects. For bladder symptoms, inherited differences in how tolterodine is broken down can raise drug levels, making a dose change or another option like oxybutynin more appropriate. Anesthesia planning also matters: families with a history of malignant hyperthermia may carry muscle gene changes that require avoiding specific anesthesia drugs during surgery. Genetic testing can sometimes identify how your body handles these medicines and anesthesia, helping your team tailor pain control, bladder treatments, and surgical care. Even so, genes are only part of the picture, and many treatments for Closed spinal dysraphism aren’t strongly influenced by genetics; doctors still rely on your symptoms, kidney and liver function, and other medicines you take.
Interactions with other conditions
For many living with Closed spinal dysraphism, other health issues can shape how symptoms show up day to day. Bladder and bowel nerve changes raise the chance of urinary tract infections and constipation; when these occur, leg pain, back pain, or leakage can flare, and repeated infections may strain the kidneys over time. Orthopedic problems such as scoliosis or foot deformities often appear alongside Closed spinal dysraphism; A condition may “exacerbate” (make worse) symptoms of another, so a progressing curve or tight heel cord can intensify tethered‑cord–related weakness or gait changes. If a small skin opening (dermal sinus tract) is present, even a mild skin infection can spread inward and lead to serious spine infections like an abscess or meningitis. Some people also develop a fluid-filled cavity in the spinal cord (syringomyelia), which can add to numbness, hand weakness, or headaches. Because early symptoms of Closed spinal dysraphism can be mistaken for isolated orthopedic or urinary issues, coordinated care across neurosurgery, urology, and rehabilitation helps catch these interactions early and protect nerve and kidney health.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described newborns with a small dimple, a patch of thick hair, or a birthmark over the lower back, and some later developed leg weakness or bladder troubles as they grew. Families sometimes recalled a relative who walked a bit differently or had frequent urinary infections, with a faint skin mark in the same spot. These observations hinted at a hidden problem beneath the skin long before doctors could see it directly.
First described in the medical literature as subtle “occult” forms of spinal malformation, closed spinal dysraphism was initially recognized through outward clues on the back and the symptoms that followed in childhood. In the early 20th century, surgeons and radiologists began to connect these surface signs with tethers, fatty tissue, or other closed defects around the spinal cord. Before modern imaging, understanding often came only during surgery, when the spinal cord was found pulled down or bound by tissue.
As medical science evolved, safer anesthesia and refined surgical techniques allowed more children to be evaluated and treated, shifting the outlook from watch-and-wait toward earlier intervention when needed. The introduction of spinal ultrasound for infants and, later, MRI for people of all ages changed everything. Doctors could finally map the closed defect without an incision, identify a tethered cord or lipoma, and plan surgery to prevent nerve damage rather than respond only after it appeared.
Over time, descriptions became more precise and the condition more clearly separated from open forms of spina bifida. Clinicians recognized that closed spinal dysraphism is a spectrum: some babies have only a shallow dimple and remain well, while others have deeper tracts, fatty masses, or a low-lying cord that may lead to pain, foot deformities, or bladder issues. This range explains why some cases were missed in the past and why careful newborn skin checks and targeted imaging gained importance.
Advances in genetics and developmental biology added context, showing how early formation of the spine can be disrupted in more than one way, leading to different closed defects. These insights helped refine classifications and guide counseling, while also underscoring that many cases occur without a family history or a single identifiable cause.
In recent decades, awareness has grown as pediatricians, nurses, and midwives look closely for early skin markers over the spine and refer infants for imaging when features raise concern. Today’s history of closed spinal dysraphism is one of increasingly early recognition, clearer definitions, and care plans tailored to the specific type of defect—aimed at protecting nerve function and supporting everyday life.